Suitability of Ferrites for Biomedical Applications


Suitability of Ferrites for Biomedical Applications

Meenakshi Dhiman, Shikha Rana

This chapter aims at the latest amelioration in the biomedical application of spinel ferrites. Magnetic hyperthermia treatment of tumour cells and contrast resonance imaging of human body parts, are a few applications of spinel ferrites that have gained substantial interest nowadays. The thermo-therapeutic and radiology based diagnosis treatment has many benefits over traditional methods used for disease diagnosis and imaging treatment of chronic carcinogenic origin diseases. The various types of doped and undoped spinel ferrite nanoparticles are investigated and optimised for different biomedical applications. Through this chapter, an attempt is made to provide readers the knowledge about various required characteristics and latest used strategies for the successful implementations of spinel ferrite in biomedical applications at commercial levels.

Spinel Ferrite, Magnetic, Functionalization, Hyperthermia, Drug Delivery, Magnetic Resonance Imaging

Published online , 27 pages

Citation: Meenakshi Dhiman, Shikha Rana, Suitability of Ferrites for Biomedical Applications, Materials Research Foundations, Vol. 112, pp 162-188, 2021


Part of the book on Ferrite

[1] M. Dhiman, S. Rana, M. Singh, and J. K. Sharma, “Magnetic studies of mixed Mg–Mn ferrite suitable for biomedical applications,” Integr. Ferroelectr., vol. 202, no. 1, pp. 29–38, 2019,
[2] Y. Fu et al., “Copper ferrite-graphene hybrid: A multifunctional heteroarchitecture for photocatalysis and energy storage,” Ind. Eng. Chem. Res., vol. 51, no. 36, pp. 11700–11709, 2012,
[3] P. Bhattacharya, S. Dhibar, G. Hatui, A. Mandal, T. Das, and C. K. Das, “Graphene decorated with hexagonal shaped M-type ferrite and polyaniline wrapper: A potential candidate for electromagnetic wave absorbing and energy storage device applications,” RSC Adv., vol. 4, no. 33, pp. 17039–17053, 2014,
[4] S. Rana, A. Sharma, A. Kumar, S. S. Kanwar, and M. Singh, “Utility of Silane-Modified Magnesium-Based Magnetic Nanoparticles for Efficient Immobilization of Bacillus thermoamylovorans Lipase,” Appl. Biochem. Biotechnol., vol. 192, no. 3, pp. 1029–1043, 2020,
[5] N. S. Chen, X. J. Yang, E. S. Liu, and J. L. Huang, “Reducing gas-sensing properties of ferrite compounds MFe2O4 (M = Cu, Zn, Cd and Mg),” Sensors Actuators, B Chem., vol. 66, no. 1, pp. 178–180, 2000,
[6] M. S. Dahiya, V. K. Tomer, and S. Duhan, Metal-ferrite nanocomposites for targeted drug delivery. Elsevier Inc., 2018
[7] N. Alghamdi et al., “Structural, magnetic and toxicity studies of ferrite particles employed as contrast agents for magnetic resonance imaging thermometry,” J. Magn. Magn. Mater., no. October, 2019,
[8] A. Meidanchi and H. Ansari, “Copper Spinel Ferrite Superparamagnetic Nanoparticles as a Novel Radiotherapy Enhancer Effect in Cancer Treatment,” J. Clust. Sci., vol. 32, no. 3, pp. 657–663, 2021,
[9] Y. J. Tu, C. K. Chang, C. F. You, and S. L. Wang, “Treatment of complex heavy metal wastewater using a multi-staged ferrite process,” J. Hazard. Mater., vol. 209–210, pp. 379–384, 2012,
[10] G. Kumar, R. Rani, V. Singh, S. Sharma, K. M. Batoo, and M. Singh, “Magnetic study of nano-crystalline cobalt substituted mg-mn ferrites processed via solution combustion technique,” Adv. Mater. Lett., vol. 4, no. 9, pp. 682–687, 2013,
[11] N. Rezlescu and E. Rezlescu, “Dielectric properties of copper containing ferrites,” Phys. Status Solidi, vol. 23, no. 2, pp. 575–582, 1974,
[12] M. Dhiman, S. Rana, Sanansha, N. Kumar, M. Singh, and J. K. Sharma, “Influence of Ho3+ substitution on structural and magnetic properties of Mg–Mn ferrites,” J. Mater. Sci. Mater. Electron., vol. 32, no. 7, pp. 8756–8766, 2021,
[13] H. Wang, Y. Song, X. Ye, H. Wang, W. Liu, and L. Yan, Asymmetric Supercapacitors Assembled by Dual Spinel Ferrites@Graphene Nanocomposites as Electrodes, vol. 1, no. 7. 2018
[14] M. Dhiman, S. Rana, K. Batoo, J. K. Sharma, and M. Singh, “Synthesis and characterization of Y and Sm doped Mg nanoferrites,” Integr. Ferroelectr., vol. 184, no. 1, pp. 151–157, 2017,
[15] H. Shokrollahi and K. Janghorban, “Influence of additives on the magnetic properties, microstructure and densification of Mn-Zn soft ferrites,” Mater. Sci. Eng. B Solid-State Mater. Adv. Technol., vol. 141, no. 3, pp. 91–107, 2007,
[16] M. Tadic, S. Kralj, M. Jagodic, D. Hanzel, and D. Makovec, “Magnetic properties of novel superparamagnetic iron oxide nanoclusters and their peculiarity under annealing treatment,” Appl. Surf. Sci., vol. 322, pp. 255–264, 2014,
[17] Y. Matsuoka McClain, Handbook of Modern. 1981
[18] A. Globus, H. Pascard, and V. Cagan, “and Fundamental Properties in Ferrites,” no. 4, pp. 163–168, 1977
[19] R. M. Bozorth, E. F. Tilden, and A. J. Williams, “Anisotropy and magnetostriction of some ferrites,” Phys. Rev., vol. 99, no. 6, pp. 1788–1798, 1955,
[20] S. Singhal and K. Chandra, “Cation distribution and magnetic properties in chromium-substituted nickel ferrites prepared using aerosol route,” J. Solid State Chem., vol. 180, no. 1, pp. 296–300, 2007,
[21] M. Gorgizadeh, N. Azarpira, M. Lotfi, F. Daneshvar, F. Salehi, and N. Sattarahmady, “Sonodynamic cancer therapy by a nickel ferrite/carbon nanocomposite on melanoma tumor: In vitro and in vivo studies,” Photodiagnosis Photodyn. Ther., vol. 27, no. March, pp. 27–33, 2019,
[22] P. Sharma et al., “Nanomaterial Fungicides: In Vitro and In Vivo Antimycotic Activity of Cobalt and Nickel Nanoferrites on Phytopathogenic Fungi,” Glob. Challenges, vol. 1, no. 9, p. 1700041, 2017,
[23] P. L. Venugopalan, R. Sai, Y. Chandorkar, B. Basu, S. Shivashankar, and A. Ghosh, “Conformal cytocompatible ferrite coatings facilitate the realization of a nanovoyager in human blood,” Nano Lett., vol. 14, no. 4, pp. 1968–1975, 2014,
[24] M. S. Al-Qubaisi et al., “Cytotoxicity of nickel zinc ferrite nanoparticles on cancer cells of epithelial origin,” Int. J. Nanomedicine, vol. 8, pp. 2497–2508, 2013,
[25] M. Maaß, A. Griessner, V. Steixner, and C. Zierhofer, “Reduction of eddy current losses in inductive transmission systems with ferrite sheets,” Biomed. Eng. Online, vol. 16, no. 1, pp. 1–18, 2017,
[26] M. Ansari, A. Bigham, and H. A. Ahangar, “Super-paramagnetic nanostructured CuZnMg mixed spinel ferrite for bone tissue regeneration,” Mater. Sci. Eng. C, vol. 105, no. August, p. 110084, 2019,
[27] G. C. Lavorato, R. Das, J. Alonso Masa, M. H. Phan, and H. Srikanth, “Hybrid magnetic nanoparticles as efficient nanoheaters in biomedical applications,” Nanoscale Adv., vol. 3, no. 4, pp. 867–888, 2021,
[28] A. Vashist, A. Vashist, Y. K. Gupta, and S. Ahmad, “Recent advances in hydrogel based drug delivery systems for the human body,” J. Mater. Chem. B, vol. 2, no. 2, pp. 147–166, 2014,
[29] K. M. L. Taylor-Pashow, J. Della Rocca, R. C. Huxford, and W. Lin, “Hybrid nanomaterials for biomedical applications,” Chem. Commun., vol. 46, no. 32, pp. 5832–5849, 2010,
[30] T. N. Pham, T. Q. Huy, and A. T. Le, “Spinel ferrite (AFe2O4)-based heterostructured designs for lithium-ion battery, environmental monitoring, and biomedical applications,” RSC Adv., vol. 10, no. 52, pp. 31622–31661, 2020,
[31] L. H. Reddy, J. L. Arias, J. Nicolas, and P. Couvreur, “Magnetic nanoparticles: Design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications,” Chem. Rev., vol. 112, no. 11, pp. 5818–5878, 2012,
[32] J. S. Smart, “The Néel Theory of Ferrimagnetism,” Am. J. Phys., vol. 23, no. 6, pp. 356–370, 1955,
[33] K. M. Krishnan, “Biomedical nanomagnetics: A spin through possibilities in imaging, diagnostics, and therapy,” IEEE Trans. Magn., vol. 46, no. 7, pp. 2523–2558, 2010,
[34] L. Zhou et al., “Development of carbon nanotubes/CoFe2O4 magnetic hybrid material for removal of tetrabromobisphenol A and Pb(II),” J. Hazard. Mater., vol. 265, pp. 104–114, 2014,
[35] A. A. Abd Elrahman and F. R. Mansour, “Targeted magnetic iron oxide nanoparticles: Preparation, functionalization and biomedical application,” J. Drug Deliv. Sci. Technol., vol. 52, no. May, pp. 702–712, 2019,
[36] C. Su, “Environmental implications and applications of engineered nanoscale magnetite and its hybrid nanocomposites: A review of recent literature,” J. Hazard. Mater., vol. 322, pp. 48–84, 2017,
[37] I. Sharifi, H. Shokrollahi, and S. Amiri, “Ferrite-based magnetic nanofluids used in hyperthermia applications,” J. Magn. Magn. Mater., vol. 324, no. 6, pp. 903–915, 2012,
[38] C. S. S. R. Kumar and F. Mohammad, “Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery,” Adv. Drug Deliv. Rev., vol. 63, no. 9, pp. 789–808, 2011,
[39] A. Sohail, Z. Ahmad, O. A. Bég, S. Arshad, and L. Sherin, “Revue sur le traitement par hyperthermie médiée par nanoparticules,” Bull. Cancer, vol. 104, no. 5, pp. 452–461, 2017,
[40] Suriyanto, E. Y. K. Ng, and S. D. Kumar, “Physical mechanism and modeling of heat generation and transfer in magnetic fluid hyperthermia through Néelian and Brownian relaxation: a review,” Biomed. Eng. Online, vol. 16, no. 1, p. 36, 2017,
[41] Z. Hedayatnasab, F. Abnisa, and W. M. A. Wan Daud, “Investigation properties of superparamagnetic nanoparticles and magnetic field-dependent hyperthermia therapy,” IOP Conf. Ser. Mater. Sci. Eng., vol. 334, no. 1, 2018,
[42] “coley1891[42].pdf.”
[43] R. K. GILCHRIST, R. MEDAL, W. D. SHOREY, R. C. HANSELMAN, J. C. PARROTT, and C. B. TAYLOR, “Selective inductive heating of lymph nodes,” Ann. Surg., vol. 146, no. 4, pp. 596–606, 1957,
[44] Z. Hedayatnasab, F. Abnisa, and W. M. A. W. Daud, “Review on magnetic nanoparticles for magnetic nanofluid hyperthermia application,” Mater. Des., vol. 123, pp. 174–196, 2017,
[45] D. C.F. Chan, D. B. Kirpotin, and P. A. Bunn Jr., “Synthesis and evaluation of colloidal magnetic iron oxides for the site-specific radiofrequency-induced hyperthermia of cancer,” J. Magn. Magn. Mater., vol. 122, no. 1–3, pp. 374–378, 1993,
[46] “shinkai1996[46].pdf.”
[47] A. Jordan et al., “Effects of Magnetic Fluid Hyperthermia (MFH) on C3H mammary carcinoma in vivo,” Int. J. Hyperth., vol. 13, no. 6, pp. 587–605, 1997,
[48] “J.1349-7006.1996.Tb03129.X.Pdf.”
[49] R. Hergt et al., “Physical limits of hyperthermia using magnetite fine particles,” IEEE Trans. Magn., vol. 34, no. 5 PART 2, p. 37453754, 1998
[50] H. Y. Son, A. Nishikawa, T. Ikeda, T. Imazawa, S. Kimura, and M. Hirose, “Effect of functional magnetic particles on radiofrequency capacitive heating: An in vivo study,” Japanese J. Cancer Res., vol. 93, no. 1, pp. 103–108, 2002,
[51] S. Lee and K. Na, “Oleic acid conjugated polymeric photosensitizer for metastatic cancer targeting in photodynamic therapy,” Biomater. Res., vol. 24, no. 1, pp. 1–8, 2020,
[52] P. B. Kharat, S. B. Somvanshi, P. P. Khirade, and K. M. Jadhav, “Induction heating analysis of surface-functionalized nanoscale CoFe2O4for magnetic fluid hyperthermia toward noninvasive cancer treatment,” ACS Omega, vol. 5, no. 36, pp. 23378–23384, 2020,
[53] S. B. Somvanshi et al., “Hyperthermic evaluation of oleic acid coated nano-spinel magnesium ferrite: Enhancement via hydrophobic-to-hydrophilic surface transformation,” J. Alloys Compd., vol. 835, p. 155422, 2020,
[54] C. E. Demirci Dönmez, P. K. Manna, R. Nickel, S. Aktürk, and J. Van Lierop, “Comparative Heating Efficiency of Cobalt-, Manganese-, and Nickel-Ferrite Nanoparticles for a Hyperthermia Agent in Biomedicines,” ACS Appl. Mater. Interfaces, vol. 11, no. 7, pp. 6858–6866, 2019,
[55] C. Fisher, A. E. Rider, Z. Jun Han, S. Kumar, I. Levchenko, and K. Ostrikov, “Applications and nanotoxicity of carbon nanotubes and graphene in biomedicine,” J. Nanomater., vol. 2012, 2012,
[56] P. Seal, M. Hazarika, N. Paul, and J. P. Borah, “MWCNT-MnFe2O4 nanocomposite for efficient hyperthermia applications,” AIP Conf. Proc., vol. 1942, 2018,
[57] A. Bhardwaj, K. Parekh, and N. Jain, “In vitro hyperthermic effect of magnetic fluid on cervical and breast cancer cells,” Sci. Rep., vol. 10, no. 1, pp. 1–13, 2020,
[58] J. Sánchez, M. Rodríguez-Reyes, D. A. Cortés-Hernández, C. A. Ávila-Orta, and P. Y. Reyes-Rodríguez, “Heating capacity and biocompatibility of Pluronic-coated manganese gallium ferrites for magnetic hyperthermia treatment,” Colloids Surfaces A Physicochem. Eng. Asp., vol. 612, no. July 2020, 2021,
[59] M. S. A. Darwish, H. Kim, H. Lee, C. Ryu, J. Y. Lee, and J. Yoon, “Engineering core-shell structures of magnetic ferrite nanoparticles for high hyperthermia performance,” Nanomaterials, vol. 10, no. 5, pp. 1–16, 2020,
[60] A. Das, S. Mohanty, R. Kumar, and B. K. Kuanr, “Tailoring the Design of a Lanthanide Complex/Magnetic Ferrite Nanocomposite for Efficient Photoluminescence and Magnetic Hyperthermia Performance,” ACS Appl. Mater. Interfaces, vol. 12, no. 37, pp. 42016–42029, 2020,
[61] O. M. Lemine, N. Madkhali, M. Hjiri, N. A. All, and M. S. Aida, “Comparative heating efficiency of hematite (α-Fe2O3) and nickel ferrite nanoparticles for magnetic hyperthermia application,” Ceram. Int., vol. 46, no. 18, pp. 28821–28827, 2020,
[62] A. Mallick, A. S. Mahapatra, A. Mitra, J. M. Greneche, R. S. Ningthoujam, and P. K. Chakrabarti, “Magnetic properties and bio-medical applications in hyperthermia of lithium zinc ferrite nanoparticles integrated with reduced graphene oxide,” J. Appl. Phys., vol. 123, no. 5, 2018,
[63] D. Lachowicz et al., “Enhanced hyperthermic properties of biocompatible zinc ferrite nanoparticles with a charged polysaccharide coating,” J. Mater. Chem. B, vol. 7, no. 18, pp. 2962–2973, 2019,
[64] S. O. Aisida et al., “The role of polyethylene glycol on the microstructural, magnetic and specific absorption rate in thermoablation properties of Mn-Zn ferrite nanoparticles by sol–gel protocol,” Eur. Polym. J., vol. 132, no. May, p. 109739, 2020,
[65] H. Nehoff, N. N. Parayath, L. Domanovitch, S. Taurin, and K. Greish, “Nanomedicine for drug targeting: Strategies beyond the enhanced permeability and retention effect,” Int. J. Nanomedicine, vol. 9, no. 1, pp. 2539–2555, 2014,
[66] S. Biswas and V. P. Torchilin, “Nanopreparations for organelle-specific delivery in cancer,” Adv. Drug Deliv. Rev., vol. 66, pp. 26–41, 2014,
[67] H. Maeda, “The enhanced permeability and retention (EPR) effect in tumor vasculature: The key role of tumor-selective macromolecular drug targeting,” Adv. Enzyme Regul., vol. 41, no. 1, pp. 189–207, 2001,
[68] H. Maeda, G. Y. Bharate, and J. Daruwalla, “Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect,” Eur. J. Pharm. Biopharm., vol. 71, no. 3, pp. 409–419, 2009,
[69] P. Kumari, B. Ghosh, and S. Biswas, “Nanocarriers for cancer-targeted drug delivery,” J. Drug Target., vol. 24, no. 3, pp. 179–191, 2016,
[70] J. Su et al., “Long Circulation Red-Blood-Cell-Mimetic Nanoparticles with Peptide-Enhanced Tumor Penetration for Simultaneously Inhibiting Growth and Lung Metastasis of Breast Cancer,” Adv. Funct. Mater., vol. 26, no. 8, pp. 1243–1252, 2016,
[71] X. Yang et al., “Tumor Microenvironment-Responsive Dual Drug Dimer-Loaded PEGylated Bilirubin Nanoparticles for Improved Drug Delivery and Enhanced Immune-Chemotherapy of Breast Cancer,” Adv. Funct. Mater., vol. 29, no. 32, pp. 1–12, 2019,
[72] O. C. Olson and J. A. Joyce, “Cysteine cathepsin proteases: Regulators of cancer progression and therapeutic response,” Nat. Rev. Cancer, vol. 15, no. 12, pp. 712–729, 2015,
[73] Z. Karimi, L. Karimi, and H. Shokrollahi, “Nano-magnetic particles used in biomedicine: Core and coating materials,” Mater. Sci. Eng. C, vol. 33, no. 5, pp. 2465–2475, 2013,
[74] M. Angelakeris, “Magnetic nanoparticles: A multifunctional vehicle for modern theranostics,” Biochim. Biophys. Acta – Gen. Subj., vol. 1861, no. 6, pp. 1642–1651, 2017,
[75] M. Arruebo, R. Fernández-Pacheco, M. R. Ibarra, and J. Santamaría, “Magnetic nanoparticles for drug delivery The potential of magnetic NPs stems from the intrinsic properties of their magnetic cores combined with their drug loading capability and the biochemical properties that can be bestowed on them by means of a suitab,” vol. 2, no. 3, pp. 22–32, 2007, [Online]. Available:
[76] F. Xiong, S. Huang, and N. Gu, “Magnetic nanoparticles: recent developments in drug delivery system,” Drug Dev. Ind. Pharm., vol. 44, no. 5, pp. 697–706, 2018,
[77] J. Kudr et al., “Magnetic nanoparticles: From design and synthesis to real world applications,” Nanomaterials, vol. 7, no. 9, 2017,
[78] S. Ahadian et al., “Micro and nanoscale technologies in oral drug delivery,” Adv. Drug Deliv. Rev., vol. 157, pp. 37–62, 2020,
[79] J. Cao, D. Huang, and N. A. Peppas, “Advanced engineered nanoparticulate platforms to address key biological barriers for delivering chemotherapeutic agents to target sites,” Adv. Drug Deliv. Rev., vol. 167, pp. 170–188, 2020,
[80] F. Laffleur and V. Keckeis, “Advances in drug delivery systems: Work in progress still needed?,” Int. J. Pharm. X, vol. 2, no. March, 2020,
[81] K. Park, “Controlled drug delivery systems: Past forward and future back,” J. Control. Release, vol. 190, pp. 3–8, 2014,
[82] P. Fomby et al., “Stem cells and cell therapies in lung biology and diseases: Conference report,” Ann. Am. Thorac. Soc., vol. 12, no. 3, pp. 181–204, 2010,
[83] B. T. Mai, S. Fernandes, P. B. Balakrishnan, and T. Pellegrino, “Nanosystems Based on Magnetic Nanoparticles and Thermo- or pH-Responsive Polymers: An Update and Future Perspectives,” Acc. Chem. Res., vol. 51, no. 5, pp. 999–1013, 2018,
[84] Z. Wang, X. Deng, J. Ding, W. Zhou, X. Zheng, and G. Tang, “Mechanisms of drug release in pH-sensitive micelles for tumour targeted drug delivery system: A review,” Int. J. Pharm., vol. 535, no. 1–2, pp. 253–260, 2018,
[85] W. Il Choi, A. Sahu, F. R. Wurm, and S. M. Jo, “Magnetoliposomes with size controllable insertion of magnetic nanoparticles for efficient targeting of cancer cells,” RSC Adv., vol. 9, no. 26, pp. 15053–15060, 2019,
[86] B. D. Cardoso et al., “Magnetoliposomes containing magnesium ferrite nanoparticles as nanocarriers for the model drug curcumin,” R. Soc. Open Sci., vol. 5, no. 10, 2018,
[87] S. Kamaraj, U. M. Palanisamy, M. S. B. Kadhar Mohamed, A. Gangasalam, G. A. Maria, and R. Kandasamy, “Curcumin drug delivery by vanillin-chitosan coated with calcium ferrite hybrid nanoparticles as carrier,” Eur. J. Pharm. Sci., vol. 116, no. January, pp. 48–60, 2018,
[88] J. Panda et al., “Anticancer potential of docetaxel-loaded cobalt ferrite nanocarrier: an in vitro study on MCF-7 and MDA-MB-231 cell lines,” J. Microencapsul., vol. 38, no. 1, pp. 36–46, 2021,
[89] X. H. Wang, M. Huang, C. K. Zhao, C. Li, and L. Xu, “Design, synthesis, and biological activity evaluation of campthothecin-HAA-Norcantharidin conjugates as antitumor agents in vitro,” Chem. Biol. Drug Des., vol. 93, no. 6, pp. 986–992, 2019,
[90] I. V. M. V. Enoch, S. Ramasamy, S. Mohiyuddin, P. Gopinath, and R. Manoharan, “Cyclodextrin-PEG conjugate-wrapped magnetic ferrite nanoparticles for enhanced drug loading and release,” Appl. Nanosci., vol. 8, no. 3, pp. 273–284, 2018,
[91] S. Ramasamy, I. V. M. V. Enoch, and S. Rex Jeya Rajkumar, “Polymeric cyclodextrin-dextran spooled nickel ferrite nanoparticles: Expanded anticancer efficacy of loaded camptothecin,” Mater. Lett., vol. 261, p. 127114, 2020,
[92] O. Veiseh, J. W. Gunn, and M. Zhang, “Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging,” Adv. Drug Deliv. Rev., vol. 62, no. 3, pp. 284–304, 2010,
[93] L. Wu, A. Mendoza-Garcia, Q. Li, and S. Sun, “Organic Phase Syntheses of Magnetic Nanoparticles and Their Applications,” Chem. Rev., vol. 116, no. 18, pp. 10473–10512, 2016,
[94] H. Zhang et al., “Ultrasmall Ferrite Nanoparticles Synthesized via Dynamic Simultaneous Thermal Decomposition for High-Performance and Multifunctional T1 Magnetic Resonance Imaging Contrast Agent,” ACS Nano, vol. 11, no. 4, pp. 3614–3631, 2017,
[95] D. Ni, W. Bu, E. B. Ehlerding, W. Cai, and J. Shi, “Engineering of inorganic nanoparticles as magnetic resonance imaging contrast agents,” Chem. Soc. Rev., vol. 46, no. 23, pp. 7438–7468, 2017,
[96] J. Wallyn and N. Anton, “Biomedical Imaging : Principles , Technologies , Clinical Aspects , C o n t r a s t A g e n t s , L i m i t a t i o n s a n d F u t u r e Tr e n d s in Nanomedicines,” pp. 1–31, 2019
[97] Y. Miao et al., “Composition-tunable ultrasmall manganese ferrite nanoparticles: Insights into their in vivo T1 contrast efficacy,” Theranostics, vol. 9, no. 6, pp. 1764–1776, 2019,
[98] Z. Zhou, L. Yang, J. Gao, and X. Chen, “Structure–Relaxivity Relationships of Magnetic Nanoparticles for Magnetic Resonance Imaging,” Adv. Mater., vol. 31, no. 8, pp. 1–32, 2019,
[99] D. Dheer, J. Nicolas, and R. Shankar, “Cathepsin-sensitive nanoscale drug delivery systems for cancer therapy and other diseases,” Adv. Drug Deliv. Rev., vol. 151–152, pp. 130–151, 2019,
[100] Y. Wang et al., “Engineering ferrite nanoparticles with enhanced magnetic response for advanced biomedical applications,” Mater. Today Adv., vol. 8, 2020,
[101] D. H. Kim, H. Zeng, T. C. Ng, and C. S. Brazel, “T1 and T2 relaxivities of succimer-coated MFe23+O4 (M=Mn2+, Fe2+ and Co2+) inverse spinel ferrites for potential use as phase-contrast agents in medical MRI,” J. Magn. Magn. Mater., vol. 321, no. 23, pp. 3899–3904, 2009,
[102] F. Hyder and S. Manjura Hoque, “Brain tumor diagnostics and therapeutics with superparamagnetic ferrite nanoparticles,” Contrast Media Mol. Imaging, vol. 2017, 2017,
[103] H. Shokrollahi, A. Khorramdin, and G. Isapour, “Magnetic resonance imaging by using nano-magnetic particles,” J. Magn. Magn. Mater., vol. 369, pp. 176–183, 2014,
[104] G. Basina et al., “Water-soluble spinel ferrites by a modified polyol process as contrast agents in MRI,” AIP Conf. Proc., vol. 1311, no. 2010, pp. 441–446, 2010,
[105] Y. Sun et al., “High-Performance Worm-like Mn-Zn Ferrite Theranostic Nanoagents and the Application on Tumor Theranostics,” ACS Appl. Mater. Interfaces, vol. 11, no. 33, pp. 29536–29548, 2019,
[106] L. Ansari et al., “Synthesis, Characterization and MRI Application of Cobalt-Zinc Ferrite Nanoparticles Coated with DMSA: An In-vivo Study,” Appl. Magn. Reson., vol. 52, no. 1, pp. 33–45, 2021,